Regarding curcumin, studies have shown that it can downregulate COX-2 expression and PGE2 synthesis in vitro (102) and in animal models of depression (103), highlighting its potential role as an alternative natural COX-2 inhibitor option. Here, PTGS2 is linked to depressive symptom measurement.